Home/Filings/4/0001415889-25-015676
4//SEC Filing

Deflin Gayle 4

Accession 0001415889-25-015676

CIK 0001297184other

Filed

Jun 3, 8:00 PM ET

Accepted

Jun 4, 7:45 PM ET

Size

6.9 KB

Accession

0001415889-25-015676

Insider Transaction Report

Form 4
Period: 2025-06-02
Deflin Gayle
Director
Transactions
  • Award

    Stock Option (right to buy)

    2025-06-02+11,40211,402 total
    Exercise: $25.38Exp: 2035-06-02Common Stock (11,402 underlying)
  • Award

    Common Stock

    2025-06-02+5,12210,914 total
Footnotes (2)
  • [F1]The reported shares are represented by restricted stock units, or RSUs, all of which vest on June 2, 2026.
  • [F2]All of the shares subject to the option vest on June 2, 2026.

Issuer

Amphastar Pharmaceuticals, Inc.

CIK 0001297184

Entity typeother

Related Parties

1
  • filerCIK 0001866024

Filing Metadata

Form type
4
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 7:45 PM ET
Size
6.9 KB